Drug resistance gene transfer: Stem cell protection and therapeutic efficacy

This publication has 27 references indexed in Scilit:

• Chemotaxis of primitive hematopoietic cells in response to stromal cell–derived factor-1
  Journal of Clinical Investigation, 2000
• Characterization of the P140K, PVP(138-140)MLK, and G156A O⁶-Methylguanine-DNA Methyltransferase Mutants: Implications for Drug Resistance Gene Therapy
  Human Gene Therapy, 1999
• Retroviral Marking and Transplantation of Rhesus Hematopoietic Cells by Nonmyeloablative Conditioning
  Human Gene Therapy, 1999
• Human long-term culture initiating cells are sensitive to benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and protected after mutant (G156A) methylguanine methyltransferase gene transfer
  Cancer Gene Therapy, 1999
• Delta MGMT-Transduced Bone Marrow Infusion Increases Tolerance to O6-Benzylguanine and 1,3-Bis(2-chloroethyl)1-nitrosourea and Allows Intensive Therapy of 1,3-Bis(2-chloroethyl)-1-nitrosourea-Resistant Human Colon Cancer Xenografts
  Human Gene Therapy, 1999
• Effects of Retroviral-Mediated MDR1 Expression on Hematopoietic Stem Cell Self-Renewal and Differentiation in Culturea
  Annals of the New York Academy of Sciences, 1999
• No Discrepancy between in Vivo Gene Marking Efficiency Assessed in Peripheral Blood Populations Compared with Bone Marrow Progenitors or CD34+ Cells
  Human Gene Therapy, 1999
• FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cells
  Gene Therapy, 1998
• Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
  The Journal of Experimental Medicine, 1996
• Bicistronic and Two-Gene Retroviral Vectors for UsingMDR1 as a Selectable Marker and a Therapeutic Gene
  Virology, 1996